Oxford BioMedica PLC (OXBDF)

Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. It operates through following segments: Platform and Product. The Platform segment consists of the revenue generating bioprocessing and process development activities undertaken for third parties. The Product segment includes clinical and preclinical development of in vivo and ex vivo gene and cell therapy products which are owned by the group. The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom.

Data as of 2021-06-13 09:03:26 -0400
Market Cap1.417 Billion Shares Outstanding82.55 Million Avg 30-day Volume1.071 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low17.16 / 8.75 Next Earnings Date2021-09-01 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding OXBDF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OXBDF BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Millennium International Management LP OXFORD BIOMEDICA PLC 0.48% 2015-04-09 UK
Millennium International Management LP OXFORD BIOMEDICA PLC 0.57% 2015-04-08 UK
Millennium International Management LP OXFORD BIOMEDICA PLC 0.65% 2015-03-20 UK
Wellington Management Company, LLP OXFORD BIOMEDICA PLC 0.81% 2015-10-05 UK
Wellington Management Company, LLP OXFORD BIOMEDICA PLC 0.93% 2015-07-02 UK
Wellington Management Company, LLP OXFORD BIOMEDICA PLC 0.9% 2017-01-18 UK
Wellington Management Company, LLP OXFORD BIOMEDICA PLC 1.05% 2015-05-29 UK

UK Ownership History

Updated daily

Contains transactions from January 1st, 2015 on. This data is

Form Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights
TR-1 M&G Plc Oxford Biomedica Plc 2020-05-19 9,979,503 12.96%
TR-1 M&G Plc Oxford Biomedica Plc 2020-05-12 10,509,642 13.65%
TR-1 M&G Plc Oxford Biomedica Plc 2020-04-17 11,460,464 14.9%
TR-1 Aviva plc & its subsidiaries Oxford Biomedica plc 2017-03-16 292,722,763 9.478%
TR-1 VULPES LIFE SCIENCES FUND VULPES TESTUDO FUND OXFORD BIOMEDICA PLC 2016-10-04 575,850,000 18.65%
TR-1 Aviva plc & its subsidiaries Oxford Biomedica plc 2016-09-30 282,975,178 10.47%
TR-1 Aviva plc & its subsidiaries Oxford Biomedica plc 2016-04-12 283,375,219 10.48%
TR-1 Aviva plc & its subsidiaries Oxford Biomedica plc 2016-03-10 283,550,521 10.49%
TR-1 Prudential plc group of companies Oxford Biomedica Plc 2016-02-25 490,443,106 18.14%
TR-1 VULPES LIFE SCIENCES FUND OXFORD BIOMEDICA PLC 2016-02-25 475,140,655 17.58%
TR-1 Aviva plc & its subsidiaries Oxford Biomedica plc 2016-02-25 283,550,521 10.49%
TR-1 HSBC Global Custody Nominee (UK) Ltd Oxford Biomedica plc 2016-02-23 235,000,000 8.695%
TR-1 Aviva plc & its subsidiaries Oxford Biomedica plc 2016-02-23 283,550,521 11.01%
TR-1 Aviva plc & its subsidiaries Oxford Biomedica plc 2016-02-12 267,336,115 10.39%
TR-1 Aviva plc & its subsidiaries Oxford Biomedica plc 2015-11-25 254,715,768 9.9%
TR-1 Third National Swedish Pension Fund Oxford Biomedica PLC 2015-09-01 77,176,027 2.99%
TR-1 Prudential plc group of companies Oxford Biomedica Plc 2015-08-05 462,983,605 17.99%
TR-1 Aviva plc & its subsidiaries Oxford BioMedica plc 2015-03-31 250,089,544 9.74%
Holdings in Company Oxford Biomedica plc 0 0%
Holdings in Company Oxford BioMedica plc 0 0%
Holdings in Company Oxford Biomedica Plc 0 0%
Holdings in Company Oxford Biomedica Plc 0 0%
Holdings in Company Oxford Biomedica plc 0 0%
Holdings in Company OXFORD BIOMEDICA PLC 0 0%
Holdings in Company Oxford Biomedica plc 0 0%
Holdings in Company Oxford BioMedica PLC 0 0%
Holdings in Company Oxford BioMedica plc 0 0%
Holdings in Company OXFORD BIOMEDICA PLC 0 0%
Holdings in Company Oxford Biomedica Plc 0 0%
Holdings in Company Oxford Biomedica plc 0 0%
Holdings in Company Oxford BioMedica plc 0 0%
Holdings in Company Oxford Biomedica PLC 0 0%
Holdings in Company OXFORD BIOMEDICA PLC 0 0%
Holdings in Company Oxford BioMedica plc 0 0%
Holdings in Company Oxford BioMedica plc 0 0%
Holdings in Company Oxford BioMedica plc 0 0%
Holdings in Company Oxford BioMedica plc 0 0%
Holdings in Company Oxford Biomedica Plc 0 0%
Holdings in Company Oxford BioMedica plc 0 0%

Elevate your investments